基于血清蛋白质组学与机器学习识别系统性红斑狼疮并整合遗传风险分层
研究利用英国生物银行44,173名参与者的血清蛋白质组数据,开发线性和机器学习模型识别已确诊及预测未来系统性红斑狼疮,并与多基因风险评分比较。机器学习模型在识别已确诊狼疮方面表现优于线性模型,在免疫调节治疗患者中达到约90%灵敏度(95%特异度),并在瑞典和中国独立队列中重复验证。模型解释提示SCARB2、SOD2、CD302、Galectin-9和GGT5等蛋白对狼疮识别有重要贡献。
要点
- 血清蛋白质组机器学习模型可高精度识别已确诊狼疮,并可在临床诊断前预测狼疮。
- 在免疫调节治疗患者中模型达约90%灵敏度(95%特异度),独立队列重复验证。
- SCARB2、SOD2、CD302、Galectin-9和GGT5被识别为狼疮识别的新候选生物标志物。
核心结论
- 蛋白质组机器学习模型在识别已确诊狼疮方面表现优异,并能泛化用于临床诊断前预测狼疮。
- 模型解释识别出SCARB2、SOD2、CD302、Galectin-9和GGT5等新的狼疮候选生物标志物。
研究设计与样本
- 研究纳入英国生物银行有蛋白质组数据的44,173名参与者,其中2,063人在入组时至少患有一种自身免疫病,包括383例狼疮患者(发病平均年龄43.6±11.7岁)。
- 研究表征差异蛋白质组表达并进行层次聚类分析,开发蛋白质组线性模型和机器学习模型用于已确诊狼疮分类和未来狼疮预测,并与多基因风险评分比较。
- 研究使用瑞典Human Protein Atlas(HPA)和中国两个独立狼疮队列进行重复验证。
主要发现
- 狼疮在自身免疫病中显示最大数量的失调蛋白,并与类风湿关节炎聚类在一起。
- 与HPA比较显示约70%的狼疮蛋白质组关联可被重复,效应量呈中等相关。
- 机器学习模型在识别已确诊狼疮方面优于线性模型,并良好泛化用于未来狼疮预测。
- 在免疫调节治疗患者中,模型达到约90%灵敏度(95%特异度),并在独立队列中重复验证。
临床怎么用
- 血清蛋白质组机器学习模型可用于狼疮的识别和临床诊断前预测,尤其在免疫调节治疗患者中具有较高灵敏度。
- 模型解释提示的SCARB2、SOD2、CD302、Galectin-9和GGT5等蛋白可作为狼疮候选生物标志物进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Proteome-wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. METHODS: Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included. Differential proteomic expressions were characterized and followed by hierarchical clustering analysis. Proteomic linear and machine learning models were developed for established disease classification and future lupus prediction and compared to polygenic risk scores. Two additional independent lupus cohorts from Sweden, as part of the Human Protein Atlas (HPA), and from China were used for replication. RESULTS: In the UK Biobank, 44,173 participants with proteomic data, including 2,063 individuals with at least one autoimmune disease at enrollment, were studied. This included 383 patients with lupus with a mean age of 43.6 ± SD 11.7 years at disease onset. Lupus showed the largest number of dysregulated proteins among autoimmune diseases and clustered with rheumatoid arthritis. Comparison with HPA showed that ~70% of lupus proteomic associations could be replicated with moderate correlation in effect sizes. The machine learning model outperformed the linear model in identifying pre-existing lupus and generalized well to future lupus prediction. Among patients with lupus on immunomodulatory medications, the model reached ~90% sensitivity at 95% specificity, which was replicated in an independent cohort. Model interpretation highlighted SCARB2, SOD2, CD302, Galectin-9, and GGT5 proteins with substantial effects on lupus identification. CONCLUSION: Proteomic machine learning models show excellent performance for identifying pre-existing lupus and generalize well for predicting lupus before clinical diagnosis. Model interpretation identified novel candidate biomarkers for lupus.
引用
- Hocaoǧlu M, Das J, Sawalha AH, et al. Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification. Arthritis Rheumatol. 2026. PMID: 41884878. doi:10.1002/art.70156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。